SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009345
Filing Date
2018-04-26
Accepted
2018-04-26 17:01:04
Documents
7
Period of Report
2018-06-07
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A mnov-def14a_20180607.htm DEF 14A 1743334
2 GRAPHIC g2018042620504937320734.jpg GRAPHIC 2463
3 GRAPHIC g2018042620505318720737.jpg GRAPHIC 25405
4 GRAPHIC g2018042620505325020738.jpg GRAPHIC 1300
5 GRAPHIC g2018042620504936820733.jpg GRAPHIC 1300
6 GRAPHIC g2018042620504936320732.jpg GRAPHIC 2463
7 GRAPHIC g2018042620504961320735.jpg GRAPHIC 1177
  Complete submission text file 0001564590-18-009345.txt   1792344
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33185 | Film No.: 18779458
SIC: 2834 Pharmaceutical Preparations